01—History
Capital Expenditures History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $192.0M
1 older move runs past ±150% (largest +317.6%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is capital expenditures?
Capital expenditures (CapEx) can be defined as money spent on acquiring, maintaining, or upgrading physical assets such as property, buildings, and equipment.
What is Moderna, Inc.'s current capital expenditures?
Moderna, Inc. (MRNA) annual capital expenditures for 2025 was $192.0M, a 81.73% decline from 2024. Moderna, Inc. capital expenditures for the quarter ending March 31, 2026 was $62.0M.
What was Moderna, Inc.'s capital expenditures in 2024?
Moderna, Inc. annual capital expenditures for 2024 was $1.05B, a 48.66% increase from 2023.
What was Moderna, Inc.'s capital expenditures in 2023?
Moderna, Inc. annual capital expenditures for 2023 was $707.0M, a 76.75% increase from 2022.
What is Moderna, Inc.'s 5-year capital expenditures CAGR?
Moderna, Inc. capital expenditures grew at a compound annual growth rate (CAGR) of 23.07% from FY2020 to FY2025, going from $68.0M to $192.0M over 5 years.
- Company
- Moderna, Inc.
- Ticker
- MRNA
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)